Cite
HARVARD Citation
Lev, S. (2020). Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis. Biochemical Society transactions. pp. 657-665. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lev, S. (2020). Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis. Biochemical Society transactions. pp. 657-665. [Online].